Paper41329239
Cell surface vimentin-positive circulating tumor cells: developments, and clinical applications.
Zhong J and 5 others. Med Oncol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Cell surface vimentin-positive circulating tumor cells: developments, and clinical applications. Papers, record 41329239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41329239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cell surface vimentin-positive circulating tumor cells: developments, and clinical applications.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Neoplasms | Major topic |
| Neoplastic Cells, Circulating | Major topic |
| Vimentin | Major topic |
| Humans | |
| Epithelial-Mesenchymal Transition | |
| Liquid Biopsy |
Source PubMed
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32017145 | Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. | Hepatology | 2021 | https://conductscience.org/library/papers/32017145 | PubMed |
| 2 | 15317891 | Circulating tumor cells, disease progression, and survival in metastatic breast cancer. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15317891 | PubMed |
| 3 | 25171411 | Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. | Cell | 2014 | https://conductscience.org/library/papers/25171411 | PubMed |
| 4 | 11744725 | Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11744725 | PubMed |
| 5 | 32550632 | Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review. | Minerva Urol Nefrol | 2020 | https://conductscience.org/library/papers/32550632 | PubMed |
| 6 | 25342631 | Revisiting STAT3 signalling in cancer: new and unexpected biological functions. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/25342631 | PubMed |
| 7 | 20389281 | The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. | EMBO J | 2010 | https://conductscience.org/library/papers/20389281 | PubMed |
| 8 | 29559380 | Circulating tumor cell isolation, culture, and downstream molecular analysis. | Biotechnol Adv | 2018 | https://conductscience.org/library/papers/29559380 | PubMed |
| 9 | 38001632 | Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38001632 | PubMed |
| 10 | 26851185 | Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/26851185 | PubMed |
| 11 | 22770212 | Cancer epigenetics: from mechanism to therapy. | Cell | 2012 | https://conductscience.org/library/papers/22770212 | PubMed |
| 12 | 34314819 | Long non-coding RNAs regulated NF-κB signaling in cancer metastasis: Micromanaging by not so small non-coding RNAs. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/34314819 | PubMed |
| 13 | 33415568 | EMT-independent detection of circulating tumor cells in human blood samples and pre-clinical mouse models of metastasis. | Clin Exp Metastasis | 2021 | https://conductscience.org/library/papers/33415568 | PubMed |
| 14 | 21378321 | A new device for rapid isolation by size and characterization of rare circulating tumor cells. | Anticancer Res | 2011 | https://conductscience.org/library/papers/21378321 | PubMed |
| 15 | 40199140 | Exosomal PD-L1 in non-small cell lung Cancer: Implications for immune evasion and resistance to immunotherapy. | Int Immunopharmacol | 2025 | https://conductscience.org/library/papers/40199140 | PubMed |
| 16 | 23563269 | Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. | Nature | 2013 | https://conductscience.org/library/papers/23563269 | PubMed |
| 17 | 38632361 | Vimentin filaments integrate low-complexity domains in a complex helical structure. | Nat Struct Mol Biol | 2024 | https://conductscience.org/library/papers/38632361 | PubMed |
| 18 | 38688773 | EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. | Eur Urol | 2024 | https://conductscience.org/library/papers/38688773 | PubMed |
| 19 | 37914786 | Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer. | Sci Rep | 2023 | https://conductscience.org/library/papers/37914786 | PubMed |
| 20 | 32148021 | Selection of Aptamers Against Vimentin for Isolation and Release of Circulating Tumor Cells Undergoing Epithelial Mesenchymal Transition. | Anal Chem | 2020 | https://conductscience.org/library/papers/32148021 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42496704 | Transcriptomic network analysis and functional evidence identify a candidate EMT hub signature associated with nasopharyngeal carcinoma progression. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42496704 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EPCAM | 4072 | PubTator's text mining | https://conductscience.org/library/genes/4072 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41329239
GET https://conductscience.org/api/papers/v1/41329239/references?page=2